Christina Sherrill

Has grant

Assistant Professor of Ambulatory Care

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christina Sherrill is an Assistant Professor of Ambulatory Care at High Point University School of Pharmacy in the United States. Her research areas focus on the role of pharmacists in diabetes management and the integration of advanced monitoring technologies into pharmacy education. Her recent publications address the impact of interprofessional education on student pharmacists and the clinical implications of incretin-based therapies for weight management.

Recent Grants

Grant: Close

Hands-on continuous glucose monitoring pedagogy to improve knowledge, empathy, and practice readiness

Open Date: 2022-09-01

Close Date: 2023-08-01

Grant: Close

Hands-on virtual continuous glucose monitoring education for students and preceptors

Open Date: 2021-07-01

Close Date: 2022-06-01

Grant: Close

Weight loss with SGLT2 inhibitor use: An uphill battle

Open Date: 2018-02-01

Close Date: 2019-07-01

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christina Sherrill

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Impact of interprofessional and simulation activities on student pharmacists' professional identity formation: A qualitative study

The Pharmacist's Role in the Use of Incretin‐Based Therapies for Weight Management: An Opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy

Integrating continuous glucose monitoring into Doctor of Pharmacy curricula

Student pharmacist counseling performance after hands-on continuous glucose monitoring education: A multi-institutional pragmatic randomized study

Reply: Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice

Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice

Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020

The pursuit of optimal semaglutide dosing in type 2 diabetes continues

Association between mental health and self-care behavior among older adults with diabetes according to Behavioral Risk Factor Surveillance System 2019

Prevalence, characteristics, and health-related quality of life of continuous glucose monitoring use according to the Behavioral Risk Factor Surveillance System 2014-2020

High-Dose Once-Weekly Semaglutide: A New Option for Obesity Management

Transition from in-person to telehealth standardized patient encounters: A retrospective analysis of 18 cases

Design and development of a continuous glucose monitoring educational module for students and practicing pharmacists

Effects of sodium-glucose cotransporter-2 inhibitors on appetite markers in patients with type 2 diabetes mellitus

Professional continuous glucose monitoring: A retrospective cohort study comparing one vs two pharmacist‐driven encounters

Effect of Pharmacist-Driven Professional Continuous Glucose Monitoring in Adults with Uncontrolled Diabetes.

Collaborators (5)

Lindsay Courtney

Jennifer Clements

Mollie Scott

Andrew Hwang

Kathryn Litten

Make your next move.